Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The Study Details page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and new metadata labels (Last verified, Last known status was), and adjusts the Intervention/Treatment label formatting. It also displays a new Revision: v3.6.0, replacing the previous version.
    Difference
    1%
    Check dated 2026-06-13T00:39:54.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing Revision: v3.5.4. This reflects a minor metadata update to the page rather than substantive changes to study content.
    Difference
    0.1%
    Check dated 2026-06-05T21:38:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.4, signaling a new release of the page; the visible study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-05-15T16:02:44.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated (from v3.5.2 to v3.5.3). This reflects a minor versioning change rather than an update to the study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:37.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:42.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaces v3.4.3; no substantive study details or eligibility criteria appear to be affected.
    Difference
    0.1%
    Check dated 2026-03-19T04:52:58.000Z thumbnail image

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.